DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Weiss GJ, Blaydorn L, Beck J. et al.
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma.
Invest New Drugs 2018;
36 (01) 96-102
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.